I had a great time speaking with Dr. Chuck Adler about how biomarkers are used in clinical and research contexts, as well as his work on the Arizona Study of Aging & Neurodegenerative Disorders & the Parkinson's Progression Markers Initiative (PPMI). 🧠📈 🧪 #scicomm

https://www.michaeljfox.org/podcast/episode-23-clinical-applications-biomarkers-and-large-scale-collaborative-research-charles